• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从(杜索尔)提取物中鉴定出作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血管紧张素转换酶2-受体结合域S1受体复合物潜在抑制剂的先导化合物:来自分子对接、ADMET特性分析和分子动力学模拟研究的见解

Identification of Leading Compounds from (Dudsor) Extracts as a Potential Inhibitor of SARS-CoV-2 ACE2-RBDS1 Receptor Complex: An Insight from Molecular Docking ADMET Profiling and MD-simulation Studies.

作者信息

Islam Md Nur, Pramanik Md Enayet Ali, Hossain Md Arju, Rahman Md Hasanur, Hossen Md Sahadot, Islam Md Ashraful, Miah M Morsed Zaman, Ahmed Istiak, Hossain Azm Mostaque, Haque Md Jawadul, Islam Akm Monoarul, Ali Md Nowshad, Jahan Rukhshana Akhter, Haque Md Enamul, Rahman Md Munzur, Hasan Md Sharif, Rahman Mohammad Motiur, Kabir Md Mamun, Basak Prabir Mohan, Sarkar Md Abdul Mumit, Islam Md Shafiqul, Rahman Md Rashedur, Prodhan Akm Azad-Ud-Doula, Mosaddik Ashik, Haque Humayra, Fahmin Fahmida, Das Haimanti Shukla, Islam Md Manzurul, Emtia Chandrima, Gofur Md Royhan, Liang Aiping, Akbar Sheikh Mohammad Fazle

机构信息

National Laboratory of Biomacromolecules, Chinese Academy of Sciences Center for Excellence in Biomacromolecules, Institute of Biophysics; University of Chinese Academy of Sciences, Beijing, People's Republic of China.

Key Laboratory of Zoological Systematics and Evolution, Institute of Zoology, College of Life Sciences, University of Chinese Academy of Sciences (UCAS), Beijing, People's Republic of China; On-Farm Research Division, Bangladesh Agricultural Research Institute, Rajshahi, Bangladesh.

出版信息

Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):89-107. doi: 10.5005/jp-journals-10018-1414.

DOI:10.5005/jp-journals-10018-1414
PMID:38222948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10785135/
Abstract

UNLABELLED

Coronavirus disease-19 (COVID-19) are deadly and infectious disease that impacts individuals in a variety of ways. Scientists have stepped up their attempts to find an antiviral drug that targets the spike protein (S) of Angiotensin converting enzyme 2 (ACE2) (receptor protein) as a viable therapeutic target for coronavirus. The most recent study examines the potential antagonistic effects of 17 phytochemicals present in the plant extraction of on the anti-SARS-CoV-2 ACE2 protein. Computational techniques like molecular docking, absorption, distribution, metabolism, excretion, and toxicity (ADMET) investigations, and molecular dynamics (MD) simulation analysis were used to investigate the actions of these phytochemicals. The results of molecular docking studies showed that the control ligand (2-acetamido-2-deoxy-β-D-glucopyranose) had a binding potential of -6.2 kcal/mol, but the binding potentials of delphin, β-amyrin, and tulipanin are greater at -10.4, 10.0, and -9.6 kcal/mol. To verify their drug-likeness, the discovered hits were put via Lipinski filters and ADMET analysis. According to MD simulations of the complex run for 100 numbers, delphin binds to the SARS-CoV-2 ACE2 receptor's active region with good stability. In root-mean-square deviation (RMSD) and root mean square fluctuation (RMSF) calculations, delphinan, β-amyrin, and tulipanin showed reduced variance with the receptor binding domain subunit 1(RBD S1) ACE2 protein complex. The solvent accessible surface area (SASA), radius of gyration (Rg), molecular surface area (MolSA), and polar surface area (PSA) validation results for these three compounds were likewise encouraging. The convenient binding energies across the 100 numbers binding period were discovered by using molecular mechanics of generalized born and surface (MM/GBSA) to estimate the ligand-binding free energies to the protein receptor. All things considered, the information points to a greater likelihood of chemicals found in binding to the SARS-CoV-2 ACE2 active site. To determine these lead compounds' anti-SARS-CoV-2 potential, in vitro and studies should be conducted.

HOW TO CITE THIS ARTICLE

Islam MN, Pramanik MEA, Hossain MA, . Identification of Leading Compounds from (Dudsor) Extracts as a Potential Inhibitor of SARS-CoV-2 ACE2-RBDS1 Receptor Complex: An Insight from Molecular Docking ADMET Profiling and MD-simulation Studies. Euroasian J Hepato-Gastroenterol 2023;13(2):89-107.

摘要

未标注

冠状病毒病-19(COVID-19)是一种致命的传染病,以多种方式影响个体。科学家们已加紧努力寻找一种靶向血管紧张素转换酶2(ACE2)(受体蛋白)的刺突蛋白(S)的抗病毒药物,作为冠状病毒的一个可行治疗靶点。最新研究考察了植物提取物中存在的17种植物化学物质对抗SARS-CoV-2 ACE2蛋白的潜在拮抗作用。使用了分子对接、吸收、分布、代谢、排泄和毒性(ADMET)研究以及分子动力学(MD)模拟分析等计算技术来研究这些植物化学物质的作用。分子对接研究结果表明,对照配体(2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖)的结合潜能为-6.2千卡/摩尔,但飞燕草素、β-香树脂醇和郁金香苷的结合潜能更大,分别为-10.4、-10.0和-9.6千卡/摩尔。为验证其类药性,将发现的命中化合物通过Lipinski过滤器和ADMET分析。根据对复合物进行100次的MD模拟,飞燕草素与SARS-CoV-2 ACE2受体的活性区域结合具有良好的稳定性。在均方根偏差(RMSD)和均方根波动(RMSF)计算中,飞燕草苷、β-香树脂醇和郁金香苷与受体结合域亚基1(RBD S1)ACE2蛋白复合物的方差减小。这三种化合物的溶剂可及表面积(SASA)、回转半径(Rg)、分子表面积(MolSA)和极性表面积(PSA)验证结果同样令人鼓舞。通过使用广义Born和表面分子力学(MM/GBSA)估计配体与蛋白质受体的结合自由能,发现在100次结合期间有便利的结合能。综合考虑,这些信息表明植物提取物中发现的化学物质更有可能与SARS-CoV-2 ACE2活性位点结合。为确定这些先导化合物的抗SARS-CoV-2潜力,应进行体外和体内研究。

如何引用本文

Islam MN, Pramanik MEA, Hossain MA, 。从植物提取物中鉴定作为SARS-CoV-2 ACE2-RBDS1受体复合物潜在抑制剂的先导化合物:来自分子对接ADMET分析和MD模拟研究的见解。《欧亚肝脏胃肠病学杂志》2023;13(2):89 - 107。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/c141cdd2ed39/ejohg-13-89-eq002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/6d42419a1e04/ejohg-13-89-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/f8861a74d202/ejohg-13-89-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/2aff6c12d2b7/ejohg-13-89-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/d1378932e04d/ejohg-13-89-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/7343cc7074b5/ejohg-13-89-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/48131821b0b7/ejohg-13-89-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/72a1f24069e9/ejohg-13-89-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/6f70a3dcd8fd/ejohg-13-89-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/c608b3f69fe1/ejohg-13-89-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/e36016f46c14/ejohg-13-89-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/165fc1516e18/ejohg-13-89-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/bdfb4d73bcbd/ejohg-13-89-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/8e921b82db6e/ejohg-13-89-eq001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/c141cdd2ed39/ejohg-13-89-eq002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/6d42419a1e04/ejohg-13-89-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/f8861a74d202/ejohg-13-89-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/2aff6c12d2b7/ejohg-13-89-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/d1378932e04d/ejohg-13-89-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/7343cc7074b5/ejohg-13-89-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/48131821b0b7/ejohg-13-89-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/72a1f24069e9/ejohg-13-89-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/6f70a3dcd8fd/ejohg-13-89-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/c608b3f69fe1/ejohg-13-89-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/e36016f46c14/ejohg-13-89-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/165fc1516e18/ejohg-13-89-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/bdfb4d73bcbd/ejohg-13-89-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/8e921b82db6e/ejohg-13-89-eq001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38f6/10785135/c141cdd2ed39/ejohg-13-89-eq002.jpg

相似文献

1
Identification of Leading Compounds from (Dudsor) Extracts as a Potential Inhibitor of SARS-CoV-2 ACE2-RBDS1 Receptor Complex: An Insight from Molecular Docking ADMET Profiling and MD-simulation Studies.从(杜索尔)提取物中鉴定出作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血管紧张素转换酶2-受体结合域S1受体复合物潜在抑制剂的先导化合物:来自分子对接、ADMET特性分析和分子动力学模拟研究的见解
Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):89-107. doi: 10.5005/jp-journals-10018-1414.
2
Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury.人血管紧张素转换酶2(hACE2)受体的活性位点特异性量子隧穿,以评估其与选择性生物活性化合物的复合构象,共同抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的内流及随后的心脏损伤。
J Adv Vet Anim Res. 2021 Sep 29;8(4):540-556. doi: 10.5455/javar.2021.h544. eCollection 2021 Dec.
3
Pea eggplant ( Swartz) is a source of plant food polyphenols with SARS-CoV inhibiting potential.豌豆茄子(Swartz)是一种具有 SARS-CoV 抑制潜力的植物多酚类食物来源。
PeerJ. 2022 Nov 29;10:e14168. doi: 10.7717/peerj.14168. eCollection 2022.
4
Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations.从抗病毒植物化学物质库中利用分子对接和分子动力学 (MD) 模拟技术,确定抑制 SARS-CoV-2 S 蛋白与 ACE2 相互作用的潜在药物靶标。
J Mol Graph Model. 2021 Jun;105:107874. doi: 10.1016/j.jmgm.2021.107874. Epub 2021 Feb 22.
5
Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: study.十种天然草药中的植物成分作为新型冠状病毒主要蛋白酶的有效抑制剂:研究
Phytomed Plus. 2021 Nov;1(4):100083. doi: 10.1016/j.phyplu.2021.100083. Epub 2021 Jun 6.
6
Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2.通过针对刺突 RBD 和人 ACE2 之间的界面区域,鉴定潜在的 SARS-CoV-2 进入抑制剂。
J Infect Public Health. 2021 Feb;14(2):227-237. doi: 10.1016/j.jiph.2020.12.014. Epub 2020 Dec 21.
7
Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域(Spike RBD)主要突变的结构与功能见解及其与人类血管紧张素转换酶2(ACE2)受体的相互作用
J King Saud Univ Sci. 2022 Feb;34(2):101773. doi: 10.1016/j.jksus.2021.101773. Epub 2021 Dec 20.
8
Plant derived active compounds as potential anti SARS-CoV-2 agents: an study.植物来源的活性化合物作为潜在的抗 SARS-CoV-2 药物:一项研究。
J Biomol Struct Dyn. 2022;40(21):10629-10650. doi: 10.1080/07391102.2021.1947384. Epub 2021 Jul 6.
9
In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis.寻找针对严重急性呼吸综合征冠状病毒2(SARS CoV-2)的RNA依赖性RNA聚合酶(RdRp)和主要蛋白酶(Mpro)抑制剂:分子对接、分子动力学模拟及药物代谢动力学/药物毒性预测分析
J Mol Struct. 2021 Sep 5;1239:130488. doi: 10.1016/j.molstruc.2021.130488. Epub 2021 Apr 21.
10
Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an approach of targeted drug designing.选择性芳香植物化学配体阻断SARS-CoV-2 S蛋白与ACE2受体结合的分子优化、对接及动态模拟分析:一种靶向药物设计方法
J Adv Vet Anim Res. 2021 Mar 5;8(1):24-35. doi: 10.5455/javar.2021.h481. eCollection 2021 Mar.

本文引用的文献

1
Leaf Juice on Mild and Moderate COVID-19 Patients: Implications in OMICRON Era.叶汁对轻症和中症新冠肺炎患者的影响:在奥密克戎时代的意义
Euroasian J Hepatogastroenterol. 2022 Jan-Jun;12(1):10-18. doi: 10.5005/jp-journals-10018-1367.
2
Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and insights.丹参酮IIA、鼠尾草酸、迷迭香酸、丹酚酸、黄芩素和甘草次酸在计算和深入研究方面的抗SARS-CoV-2活性。
RSC Adv. 2021 Sep 1;11(47):29267-29286. doi: 10.1039/d1ra05268c.
3
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
奥密克戎新冠病毒变体:新冠疫情的新篇章。
Lancet. 2021 Dec 11;398(10317):2126-2128. doi: 10.1016/S0140-6736(21)02758-6. Epub 2021 Dec 3.
4
Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and studies.特拉匹韦是一种可重新用于对抗严重急性呼吸综合征冠状病毒2的潜在药物:计算和研究。
Heliyon. 2021 Sep;7(9):e07962. doi: 10.1016/j.heliyon.2021.e07962. Epub 2021 Sep 9.
5
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.慢性肺部疾病与有利于 SARS-CoV-2 进入和严重程度的基因表达程序有关。
Nat Commun. 2021 Jul 14;12(1):4314. doi: 10.1038/s41467-021-24467-0.
6
Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.新型冠状病毒肺炎中的微生物共感染:相关共生菌群及发病机制的潜在机制。
Microb Pathog. 2021 Jul;156:104941. doi: 10.1016/j.micpath.2021.104941. Epub 2021 May 4.
7
Compounds Identified from Marine Mangrove Plant as Potential Antiviral Drug Candidates Against WDSV, an Approach.从海洋红树林植物中鉴定出的化合物作为潜在的抗病毒药物候选物对抗 WDSV 的研究方法。
Mar Drugs. 2021 Apr 28;19(5):253. doi: 10.3390/md19050253.
8
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway.全面分析 COVID-19 血液、肺部和气道的转录组学
Sci Rep. 2021 Mar 29;11(1):7052. doi: 10.1038/s41598-021-86002-x.
9
Differentially expressed immune response genes in COVID-19 patients based on disease severity.基于疾病严重程度的 COVID-19 患者差异表达免疫反应基因。
Aging (Albany NY). 2021 Mar 29;13(7):9265-9276. doi: 10.18632/aging.202877.
10
Covid-19 treatment: Investigation on the phytochemical constituents of as potential Coronavirus-2 inhibitors.新冠病毒治疗:对作为潜在的新型冠状病毒2型抑制剂的植物化学成分的研究。
Comput Toxicol. 2021 May;18:100161. doi: 10.1016/j.comtox.2021.100161. Epub 2021 Feb 18.